Mediclinic International plc Director/PDMR Shareholding (4065F)
12 July 2019 - 9:30PM
UK Regulatory
TIDMMDC
RNS Number : 4065F
Mediclinic International plc
12 July 2019
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
12 July 2019
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
On 11 July 2019, Dr Ronnie Van der Merwe purchased 11 000 shares
in Mediclinic International plc at ZAR 56.90 per share.
Accordingly, Dr Van der Merwe now owns a total of 51 630
Shares.
The following notification is made in accordance with Articles
19.1 and 19.3 of the Market Abuse Regulation.
1. Details of PDMR / persons closely associated with them
("PCA")
a) Name Dr Carel Aron van der Merwe
----------------------- ---------------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------
a) Position / status Chief Executive Officer - Mediclinic International
plc
----------------------- ---------------------------------------------------
b) Initial notification Initial Notification
/ amendment
----------------------- ---------------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
a) Name Mediclinic International plc
----------------------- ---------------------------------------------------
b) LEI 2138002S5BSBIZTD5I60
----------------------- ---------------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument GB00B8HX8Z88
Identification
Code
----------------------- ---------------------------------------------------
b) Nature of the Purchase of shares
transaction
----------------------- ---------------------------------------------------
c) Price(s) and Price(s) Volume(s)
volume(s) ZAR 56.84 per share 1 000
----------
ZAR 56.85 per share 2 831
----------
ZAR 56.86 per share 1 000
----------
ZAR 56.87 per share 3 000
----------
ZAR 56.98 per share 2 000
----------
ZAR 57.00 per share 1 169
----------
----------------------- ---------------------------------------------------
d) Aggregated information
Aggregated volume
Price
11 000
ZAR 56.90
----------------------- ---------------------------------------------------
e) Date of the 11 July 2019
transaction
----------------------- ---------------------------------------------------
f) Place of the Johannesburg Stock Exchange
transaction
----------------------- ---------------------------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare services
group, established in South Africa in 1983, with divisions in
Switzerland, Southern Africa (South Africa and Namibia) and the
United Arab Emirates.
The Group's core purpose is to enhance the quality of life.
Mediclinic is focused on providing specialist-orientated,
multi-disciplinary services across the continuum of care in such a
way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical
practitioners, funders and regulators of healthcare in each of its
markets.
Mediclinic comprises 77 hospitals, five sub-acute hospitals, 12
day case clinics and 21 outpatient clinics. Hirslanden operates 18
hospitals, two day case clinics and three outpatient clinics in
Switzerland with more than 1 900 inpatient beds; Mediclinic
Southern Africa operates 52 hospitals, five sub-acute hospitals and
12 day case clinics with more than 8 500 inpatient beds; and
Mediclinic Middle East operates seven hospitals, two day case
clinics and 21 outpatient clinics with more than 900 inpatient beds
in the United Arab Emirates.
The Company's primary listing is on the London Stock Exchange
("LSE") in the United Kingdom, with secondary listings on the JSE
Ltd in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a leading private healthcare group based in the United Kingdom
and listed on the LSE.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott - UK
+44 (0)20 3727 1000
Sherryn Schooling - South Africa
+27 (0)21 487 9000
Registered address: 6(th) Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International
plc and UBS Investment Bank
JSE Ltd sponsor: Rand Merchant Bank (A division of FirstRand
Bank Ltd)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBBGDRBGBBGCD
(END) Dow Jones Newswires
July 12, 2019 07:30 ET (11:30 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024